Publikationen, an denen er mitarbeitet ANDREA CABRERA PASTOR (4)

2011

  1. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer

    Journal of Thoracic Oncology, Vol. 6, Núm. 2, pp. 286-290

  2. Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

    Clinical and Translational Oncology, Vol. 13, Núm. 6, pp. 411-418

  3. The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients

    Lung Cancer, Vol. 72, Núm. 3, pp. 365-369

2009

  1. Expression of angiogenic genes: prognostic marker in patients with early-stage non-small cell lung cancer (NSCLC)

    EJC SUPPLEMENTS